From the publishers of JADPRO

Metastatic Triple-Negative Breast Cancer Resource Center

Advertisement

Current management of and future possibilities for triple negative breast cancer

Last Updated: Monday, October 30, 2023

An education session during the 2023 ASCO Annual Meeting reviewed management options and future directions for the treatment of TNBC, including immunotherapy, neoadjuvant carboplatin, and capecitabine and olaparib for high-risk disease.

The ASCO Post
Advertisement
News & Literature Highlights
Advertisement
Advertisement